Tech Company Financing Transactions
Access Vascular Funding Round
Access Vascular closed a $22 million Series C venture capital round on 10/30/2023. Investors included private investors.
Transaction Overview
Company Name
Announced On
10/30/2023
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds for: substantial production capacity increase of MIMIX� hydrophilic biomaterial vascular access devices,further research into the potential for MIMIX to lower catheter infection rates, and expansion of product portfolio.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
175 Middlesex Turnpike 1A
Bedford, MA 01730
USA
Bedford, MA 01730
USA
Phone
Website
Email Address
Overview
Our company was founded to solve the significant yet unmet needs in venous access. After shadowing physicians and learning about the challenge that thrombosis presents to venous access, our founders set off to develop a new, superior material to the polyurethane used in conventional venous catheters.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Biggins
Chief Financial Officer
Brad Rosenblum
VP - Operations
Brian Hanley
Browse more venture capital transactions:
Prev: 10/30/2023: Siro venture capital transaction
Next: 10/31/2023: Wirepas venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs